undamentalytics Newsletter
Sign in

F&G Annuities & Life, Inc. (FG) stock

Add to watchlist

Add holding +

NYSE: FG NYSE Life & Health Insurance Next results ~November 5, 2026

C Fundamentals grade

F&G Annuities & Life, Inc. is a US-listed company in the life & health insurance industry. Its financial year ends in December.

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders3 buying, 0 selling5 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
  • Funds137 adding, 141 cuttingOf 35 active managers that changed their stake, 18 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter F&G Annuities & Life files

Where F&G Annuities & Life stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $6.07bn, up 15.0% on a year earlier, slower than the 18.2% growth a quarter earlier. That growth ranks 3 of 14 among the life & health insurance companies we cover. The diluted share count is up 2.7% on a year earlier, which dilutes existing holders.

Our model value for F&G Annuities & Life is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 5, 2026 (estimated)

F&G Annuities & Life, Inc.'s trailing-twelve-month revenue grew 15.0% year on year, with a free-cash-flow margin of 59.9%. Where it stands out: revenue growth of 15.0% ranks 4 of 18 life & health insurance companies we cover. Where it lags: change in share count of 2.7% ranks 15 of 16 life & health insurance companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 32.4% while net income grew 22.9%: a 55pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 15.0% over the last 12 months, against a median of 7.0% for life & health insurance companies we cover.
  • Strong cash generation. 59.9% of revenue turned into free cash flow.

Things to watch

  • Share dilution. Diluted shares rose 2.7% in a year.
  • Growth easing. The growth rate is 3.2 points lower than a quarter earlier.
  • Below peers: change in growth rate. Change in growth rate of -3.2pp ranks 16 of 18 life & health insurance companies we cover (median +1.5pp).
  • Heavily shorted. 13.8% of the shares available to trade are sold short (5.5 days of average volume to cover).
  • Missing expectations. Earnings per share fell short of the consensus estimate in 3 of the last four quarters.
  • Estimates being cut. Analysts' consensus for next year's earnings per share has fallen 9.0% over 90 days.

Latest results: FY2026 Q2

Filed August 6, 2026
Earnings per share
$0.65 against an average estimate of $0.78: missed by 16.3%
Revenue
$1.42bn, up 4.2% on a year earlier
Share reaction
-5.5% in the first session after the results on October 5, 2026, against +1.2% for the S&P 500
Next report
November 5, 2026; average EPS estimate $0.66

F&G Annuities & Life's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+2.7%
  • 1 week+5.5%
  • 1 month-1.0%
  • This year-27.5%
  • 1 year-24.0%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$6.1B
Net margin
6.9%
EPS (TTM, diluted)
$3.11

Growth

Revenue growth
+15.0%
Change in growth rate
−3.2 pts
Share count change
+2.7%

Earnings

Last results
October 5, 2026
Next results (est.)
December 21, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Leadership
  3. Announcement
  4. Results
  5. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

F&G Annuities & Life, Inc. valuation models and calculator

No model value for F&G Annuities & Life, Inc. at the moment. Current status: valuation models disagree too widely to rate. Available reported financials are shown below.

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valuation models disagree too widely to rate: held for review.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value F&G Annuities & Life, Inc. as an insurer, with every model that fits that kind of business. Cost of equity 8.5%: the 10-year Treasury yield (4.9%) plus a beta of 0.8 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$27 ~$18–$39 Primary model, counts double
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$21 ~$18–$26 Included
Price-to-book vs return on equity (peers) The price-to-book that peers with this return on equity trade on, from a line fitted across peers. ~$43 ~$19–$67 Included
Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. ~$0.1 ~$27–$72 Left out: out of range vs price (0.01x)
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. ~$0.3 ~$29–$52 Left out: out of range vs price (0.01x)
Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. ~$24 ~$20–$30 Included
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare F&G Annuities & Life, Inc. with life and health insurers in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 5, 2026, after the close. Analysts expect revenue of $731m and EPS of $0.66 (range $0.60 to $0.71) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $2.91 −20% $3.0bn −48%
Next $4.63 +59% $3.3bn +12%

Next year's EPS estimate has moved −9.0% in 90 days, across 2 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −17.9% on 90 days ago. In the last 30 days, 0 analysts raised F&G Annuities & Life, Inc.'s forecast and 2 cut it.

Consensus EPS forecast F&G Annuities & Life, Inc., last 90 days
$2.00 $3.00 $4.00 $5.00 $6.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $3.54 Current fiscal year, 60 days ago: $3.45 Current fiscal year, 30 days ago: $3.21 Current fiscal year, 7 days ago: $3.21 Current fiscal year, Now: $2.91 $2.91 Next fiscal year, 90 days ago: $5.09 Next fiscal year, 60 days ago: $4.97 Next fiscal year, 30 days ago: $4.85 Next fiscal year, 7 days ago: $4.85 Next fiscal year, Now: $4.63 $4.63

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $3.54$5.09
60 days ago $3.45$4.97
30 days ago $3.21$4.85
7 days ago $3.21$4.85
Now $2.91$4.63

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $0.78 $0.65 −16.3%
Mar 2026 $1.01 $0.82 −18.6%
Dec 2025 $1.20 $0.91 −24.4%
Sept 2025 $0.97 $1.22 +25.4%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

2 analysts, Nov 2026
Buy00%
Hold2100%
Sell00%

Monthly trend

  1. Nov 202622
  2. Oct 202622
  3. Sep 202622

Counts of recommendations published by analysts covering F&G Annuities & Life, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
13.8%
of tradable shares
Days to cover
5.48
at average volume
Short interest, 1 month
+14%
to October 15, 2026
Held by institutions
98%
of shares
Held by insiders
2.7%
of shares
Employees
1,173
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −24.0%

$28.54 on October 31, 2025 to $21.70

ThenNowEffect
Revenue (last 12 months) $5.3bn $6.1bn +15.0%
Net margin 6.4% 6.9% +6.9%
P/E multiple 11.0x 7.0x −36.5%
Share count 131m 134m −2.6%

Biggest factor: p/e multiple.

Last 3 years −28.2%

$30.24 on November 3, 2023 to $21.70

ThenNowEffect
Revenue (last 12 months) $3.6bn $6.1bn +70.1%
P/S multiple 1.1x 0.5x −54.5%
Share count 125m 134m −7.3%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 2023202420252026 to date
Return
FG+137%−8%−24%−28%
Industry peers (median)+19%+28%+11%+15%
S&P 500+26%+25%+18%+11%
Months that ended higher
FG75%42%33%36%
S&P 50067%75%75%46%
Largest fall from a high during the year
FG−37%−26%−37%−41%
S&P 500−10%−8%−19%−9%

Worst fall since November 22, 2022: 59% from December 2, 2024 to October 12, 2026. Getting back needed a 143% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$18.90 – $33.62
From 52-week high
−35.5%
vs 50-day average
−0.6%
vs 200-day average
−14.3%
Volatility (1 year)
40%
Beta vs S&P 500
0.78

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 7 down
typical move ±6.1%
After a week
5 up, 7 down
typical move ±9.3%
After a month
5 up, 6 down
typical move ±10.4%
Results releasedNext dayS&P 500 next day5 days21 days
October 5, 2026 −5.5% +1.2% −13.8% —
August 5, 2026 −1.7% −0.4% −10.3% −16.2%
July 8, 2026 +0.1% +0.5% +8.0% +1.3%
May 6, 2026 −8.0% +1.1% −4.5% −5.5%
February 19, 2026 −11.5% +0.5% −18.1% −17.2%
November 6, 2025 +3.0% −1.0% +10.3% +10.4%
August 6, 2025 +5.3% +0.7% +9.4% +6.5%
May 7, 2025 −13.7% +1.1% −13.5% −6.6%
February 20, 2025 −11.5% −2.1% −8.5% −23.2%
November 6, 2024 +11.1% +3.3% +12.4% +14.8%
August 5, 2024 +0.4% −2.0% −1.6% +8.9%
May 8, 2024 −1.0% +0.6% +1.3% −3.4%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

F&G Annuities & Life, Inc. in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) F&G Annuities & Life, Inc.
$3B $4B $5B $6B $7B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $3.5B Revenue (TTM), FY23 Q4: $4.5B Revenue (TTM), FY24 Q1: $5.2B Revenue (TTM), FY24 Q2: $5.2B Revenue (TTM), FY24 Q3: $5.8B Revenue (TTM), FY24 Q4: $5.7B Revenue (TTM), FY25 Q1: $5.1B Revenue (TTM), FY25 Q2: $5.3B Revenue (TTM), FY25 Q3: $5.5B Revenue (TTM), FY25 Q4: $5.7B Revenue (TTM), FY26 Q1: $6B Revenue (TTM), FY26 Q2: $6.1B $6.1B

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $3.5B
FY23 Q4 $4.5B
FY24 Q1 $5.2B
FY24 Q2 $5.2B
FY24 Q3 $5.8B
FY24 Q4 $5.7B
FY25 Q1 $5.1B
FY25 Q2 $5.3B
FY25 Q3 $5.5B
FY25 Q4 $5.7B
FY26 Q1 $6B
FY26 Q2 $6.1B
Revenue growth, TTM YoY F&G Annuities & Life, Inc.
-50% 0% 50% 100% 150% FY23 Q4 FY24 Q2 FY24 Q4 FY25 Q2 FY25 Q4 FY26 Q2 Revenue growth, TTM YoY, FY23 Q4: 91.6% Revenue growth, TTM YoY, FY24 Q1: 110.7% Revenue growth, TTM YoY, FY24 Q2: 45.9% Revenue growth, TTM YoY, FY24 Q3: 64.9% Revenue growth, TTM YoY, FY24 Q4: 27.6% Revenue growth, TTM YoY, FY25 Q1: -2.3% Revenue growth, TTM YoY, FY25 Q2: 1.4% Revenue growth, TTM YoY, FY25 Q3: -4.7% Revenue growth, TTM YoY, FY25 Q4: -0.2% Revenue growth, TTM YoY, FY26 Q1: 18.2% Revenue growth, TTM YoY, FY26 Q2: 15.0% 15.0%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 91.6%
FY24 Q1 110.7%
FY24 Q2 45.9%
FY24 Q3 64.9%
FY24 Q4 27.6%
FY25 Q1 -2.3%
FY25 Q2 1.4%
FY25 Q3 -4.7%
FY25 Q4 -0.2%
FY26 Q1 18.2%
FY26 Q2 15.0%
FCF margin (TTM) F&G Annuities & Life, Inc.
40% 60% 80% 100% 120% 140% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 128.2% FCF margin (TTM), FY23 Q4: 120.5% FCF margin (TTM), FY24 Q1: 105.5% FCF margin (TTM), FY24 Q2: 98.3% FCF margin (TTM), FY24 Q3: 110.0% FCF margin (TTM), FY24 Q4: 94.5% FCF margin (TTM), FY25 Q1: 94.9% FCF margin (TTM), FY25 Q2: 101.9% FCF margin (TTM), FY25 Q3: 75.8% FCF margin (TTM), FY25 Q4: 70.1% FCF margin (TTM), FY26 Q1: 62.9% FCF margin (TTM), FY26 Q2: 59.9% 59.9%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 128.2%
FY23 Q4 120.5%
FY24 Q1 105.5%
FY24 Q2 98.3%
FY24 Q3 110.0%
FY24 Q4 94.5%
FY25 Q1 94.9%
FY25 Q2 101.9%
FY25 Q3 75.8%
FY25 Q4 70.1%
FY26 Q1 62.9%
FY26 Q2 59.9%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 3,974 2,349 4,500 5,744 5,731 6,067
Net income 1,240 635 −58 639 265 418
Diluted EPS $11.81 $5.52 −$0.47 $4.88 $1.88 $3.11
Growth (year on year)
Revenue — −40.9% +91.6% +27.6% −0.2% +15.0%
Net income — −48.8% −109.1% — −58.5% +22.9%
Diluted EPS — −53.3% −108.5% — −61.5% +19.7%
Margins
Net margin 31.2% 27.0% −1.3% 11.1% 4.6% 6.9%
Cash flow
Cash from operations 1,871 3,171 5,834 5,999 4,681 4,335
Stock-based pay 9 12 23 29 31 34
Balance sheet
Cash 1,533 960 1,563 2,264 1,486 2,103
Total debt 977 1,114 1,760 2,195 2,270 2,239
Net debt (negative = net cash) −556 154 197 −69 784 136
Diluted shares 105m 115m 124m 131m 132m 134m
Returned to shareholders
Dividends 0 0 101 121 137 147
Buybacks 0 0 18 12 10 130
Total returned 0 0 119 133 147 277

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Dividends, buybacks and capital spending

FY2026 Q2 TTM
Buybacks (TTM)
$130M
Dividends (TTM)
$147M
Returned to shareholders
8%
of free cash flow
Buybacks, last 3 fiscal years
$40M
Diluted share count
+2.7%
year over year
Total shareholder yield
9.8%
dividends 5.2% + buybacks 4.6% of market value
Dividend payout ratio
35%
of net income paid out

Competitors: side by side with peers

Closest by revenue in life & health insurance
Last 12 months unless stated FG GL MFC JXN BHF GNW Median
Revenue, last 12 months $6.1bn $6.2bn $5.8bn $6.5bn $6.7bn $7.4bn $11.1bn
Revenue growth, last 12 months 15.0% 5.2% 5.0% 15.1% 2.6% 2.1% 6.1%
Revenue growth, 3-year average 19.4% 5.5% — 43.4% 37.8% −0.3% 4.9%
Revenue growth, latest quarter 4.2% 8.0% — −22.6% 86.2% 5.8% 6.9%
Operating margin — 24.0% — — — 0.4% 12.3%
Operating margin, 3-year average — 25.1% — — — 4.2% 15.0%
Net margin 6.9% 19.6% 68.5% 1.6% 12.5% 2.9% 6.5%
Cash from operations / revenue 71.5% 22.5% 394.9% 90.9% −8.1% 5.8% 14.6%
Free-cash-flow margin 59.9% 19.9% 390.5% 90.9% — 2.8% 19.4%
Free-cash-flow margin, 3-year average 86.7% 22.2% 152.8% 106.8% — 0.7% 21.3%
Stock pay / revenue 0.6% 0.9% 0.0% 1.6% — 0.9% 0.8%
Change in share count 2.7% −5.3% −4.3% −5.8% −2.6% −6.5% −4.7%

Median of all 18 companies we cover in life & health insurance. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

18 life & health insurance companies
Measure Company Peer median Rank
Revenue growth Growth 15.0% 7.0% 4 of 18
Change in growth rate Growth -3.2pp +1.5pp 16 of 18
Net margin Profitability 6.9% 6.9% 9 of 18
Stock pay as % of revenue Cash generation 0.6% 0.9% 3 of 8
Change in share count Balance sheet 2.7% -4.7% 15 of 16

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$3.4B
Institutions reporting
315
Shares held vs prior quarter
▲ 2.3%
Positions opened / closed
48 / 56

Top buyers and sellers, Q2 2026: 137 institutions bought and 141 sold ; the biggest buyer was Bank Of America Corp (+2.2M shares) and the biggest seller Brave Warrior Advisors, LLC (−2.9M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Fidelity National Financial, Inc. $2.5B 94.7M 74.3% 0.0%
Blackrock, Inc. $89.8M 3.4M 2.7% ▼ 17.9%
Brave Warrior Advisors, LLC $66M 2.5M 1.9% ▼ 53.6%
Bank Of America Corp $59.2M 2.2M 1.7% ▲ 5173.5%
Dimensional Fund Advisors LP $56.8M 2.1M 1.7% ▲ 44.3%
Vanguard Portfolio Management LLC $52.5M 2.0M 1.6% ▼ 0.6%
Vanguard Capital Management LLC $41.1M 1.5M 1.2% ▼ 14.8%
State Street Corp $38.1M 1.4M 1.1% ▲ 72.7%
Nomura Asset Management International Inc. $33.6M 1.3M 1.0% ▲ 0.1%
Ameriprise Financial Inc $30.8M 1.2M 0.9% ▲ 20.1%
Goldman Sachs Group Inc $29.2M 1.1M 0.9% ▲ 222.0%
First Trust Advisors LP $27.5M 1.0M 0.8% New

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not F&G Annuities & Life, Inc.'s complete shareholder register. Values are as reported by the filers ; 8 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $611,979 5 trades by 3 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $611,979 net buying
Insider Date Trade Shares Price Value
Murphy Conor CEO and President September 30, 2026 Buy 231 $21.68 $5,015
Blunt Christopher O Chief Executive Officer March 13, 2026 Buy 10,000 $20.99 $209,900
Doka Celina J. Wang Director March 13, 2026 Buy 4,760 $20.98 $99,865
Blunt Christopher O Chief Executive Officer January 2, 2026 Buy 5,000 $29.56 $147,800
Blunt Christopher O Chief Executive Officer November 19, 2025 Buy 5,000 $29.88 $149,400

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around December 21, 2026 estimated from the company's past filing pattern, not announced

  • October 5, 2026
  • August 5, 2026
  • July 8, 2026
  • May 6, 2026
  • February 19, 2026
  • November 6, 2025

Recent SEC filings

Data status

When each part of this page on F&G Annuities & Life, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

F&G Annuities & Life, Inc. in brief

What does F&G Annuities & Life, Inc. do?
F&G Annuities & Life, Inc. is a US-listed company in the life & health insurance industry. Its financial year ends in December.
What is F&G Annuities & Life, Inc.'s stock ticker?
F&G Annuities & Life, Inc. trades under the ticker FG on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is F&G Annuities & Life, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, F&G Annuities & Life, Inc. reported revenue of $6.1B, 15.0% higher than a year earlier, according to its SEC filings.
What is F&G Annuities & Life, Inc.'s free cash flow?
F&G Annuities & Life, Inc.'s free-cash-flow margin is 59.9% of revenue over the trailing twelve months.
Who are F&G Annuities & Life, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Fidelity National Financial, Inc., Blackrock, Inc. and Brave Warrior Advisors, LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is F&G Annuities & Life, Inc. buying back stock, and does it pay a dividend?
F&G Annuities & Life, Inc. spent $130M on share repurchases over the trailing twelve months, and its diluted share count still rose 2.7% over the year.
What is F&G Annuities & Life, Inc.'s market cap?
On November 2, 2026, F&G Annuities & Life, Inc.'s market capitalisation was about $2.9B, with a price-to-earnings ratio of 7.0 and net debt of $136M. Market figures come from third-party market data and may be delayed.
Does F&G Annuities & Life, Inc. pay a dividend?
Yes: F&G Annuities & Life, Inc. paid $147M in dividends over the trailing twelve months, a dividend yield of 5.17% and a payout ratio of 35.2%.
Who are F&G Annuities & Life, Inc.'s competitors?
In our Life & Health Insurance peer group, the companies closest to F&G Annuities & Life, Inc. are Globe Life, Manulife Financial Corp, Jackson Financial Inc., Brighthouse Financial, Inc. and Genworth Financial Inc. The side-by-side comparison below sets their revenue, margins and growth against F&G Annuities & Life, Inc.'s.
Are insiders buying or selling F&G Annuities & Life, Inc. stock?
Over the last 12 months, F&G Annuities & Life, Inc.'s directors and officers reported 5 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
When is F&G Annuities & Life, Inc.'s next earnings date?
Around November 5, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — F&G Annuities & Life, Inc. announces its own schedule.